The mechanism of action of imatinib in these settings remains largely unknown, but multiple lines of evidence indicate that the drug can inhibit diverse cellular responses that play critical roles in driving arthritis, including inhibition of mast cell activation (via its effects on KIT) [6, 8]. Here, KIT is linked to Arthritis.